Skip to main content

Table 5 Summary of drug-related adverse events during the titration period (no. cases >1)

From: Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China

Symptoms

Cases

Number

Incidence(n=258)

Nausea

48

40

15.50%

Vomiting

31

28

10.85%

Abdominal distention

7

7

2.71%

Epigastric discomfort

4

4

1.55%

Constipation

3

3

1.16%

Anorexia

4

4

1.55%

Abdominal pain

2

2

0.78%

Total

101

90

34.88%